血清肿瘤标记物癌胚抗原、CA153和CA125检测对乳腺癌
医师杂志(电子版),2010,4(2):67-69.
[4] 张华,项明洁,毛顺露,等. 三项肿瘤标志物联合检测在乳腺癌诊断中的价值[J]. 中国实验诊断学,2015,22(1):22.
[5] 朱海龙. CEA、AFP、CA125、CA15-3、CA19-9检测对恶性肿瘤的诊断价值探讨[J]. 现代医药卫生,2016,22(22):3422-3423.
[6] Ogwaa Y,Masuzaki H,Isse N,et al. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese zucker fatty (fa/fa)rats[J]. J Clin Invest,2012,,96(3):1647-1652.
[7] 秦燕,宋玉玲,苏兆花. 血清肿瘤标记物联合动态检测在胃肠胰神经内分泌肿瘤诊断和治疗中的价值[J]. 中华临床医师杂志(电子版),2013,7(10):53-58.
[8] Gao J,Zhang Q,Xu J,et al. Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA[J]. Chin J Cancer Res,2013,25(6):743-748.
[9] Liska V,Holubec L,Treska V,et al. Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer[J]. Anticancer research,2011,31(4):1447-1451.
[10] 李凤巧. PSA、CYFRA21-1、CA153、CEA的联合检测在乳腺癌中的临床价值[J]. 医学理论与实践,2013,6(2):156-157.
[11] Di Gioia D,Heinemann V,Nagel D,et al. Kinetics of CEA and CA153 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer(MBC)[J]. Tumour Biol,2012,32(4):777-785.
[12] Park BW,Oh JW,Kim JH,et al. Preopperative CA15-3 and CEA serum levels as predictor for breast cancer outcomes[J]. Ann Oncol,2012,19(4):675-681.
[13] Pedersen AC,Sorensen PD,Jacobsen EH. Sensitivity of CA15-3,CEA and serum HER2 in the early detection of recurrence of breast cancer[J]. Chem Lab Med,2013,13(1):1-9.
[14] Ghadge MS,Naik PP,Tiwari BP,et al. A comparative study of bone scan findings and serum levels of tumor marker CA15-3 in patients with breast carcinoma[J]. Indian Journal of Clinical Biochemistry,2012,27(1):97-99.
[15] Chen Y,Zheng Y H,Lin Y Y,et al. Clinical and prognostic significance of preoperative serum CA15-3,CEA and TPS levels in patients with primary breast cancer[J]. Zhonghua Zhong Liu Za Zhi(Chinese Journal of Oncology),2011,33(11):842-846.
[16] 吕蕾,冯雪. 血清CEA、AFP、CA125、CA15-3联合检测在乳腺癌诊断中的应用价值研究[J]. 中国医药科学,2013,3(8):121-122.
[17] 潘杰,拜红霞. 乳腺癌肿瘤标志物CA153和CEA联合检测的临床价值[J]. 中国医药指南,2012,9(26):264-265.
[18] 陶晓军,陈桂明,冯晓鸿,等. 血清TK1、TPS、CA153联合检测在乳腺癌诊断中的临床价值[J]. 国际检验医学杂志,2012,3(16):1943-1944.
[19] 赵春红. 血清CA153、CA 125、CA199和CEA联合检测在乳腺癌诊断中的价值[M]. 肿瘤研究与临床,2012, 24(8):553-555.
[20] 廖洪宇,龚建. 血清CA15-3、?CA125、CEA 和PRL 水平与乳腺癌及骨转移的关系[J]. 蚌埠医学院学报,2014, 24(8):509-511.
[21] 陆永奎,胡晓桦,李永强,等. 以紫杉醇为主的联合化疗方案治疗转移性乳腺癌的临床研究[J]. 现代肿瘤医学,2015,25(2):53-55.
(收稿日期:2016-03-25)